These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7972106)

  • 21. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of HIV-1 by a double transdominant fusion gene.
    Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
    Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
    Matsukura M; Zon G; Shinozuka K; Robert-Guroff M; Shimada T; Stein CA; Mitsuya H; Wong-Staal F; Cohen JS; Broder S
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4244-8. PubMed ID: 2471199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and characterization of high-titer stocks of rev-defective HIV-1.
    Riggs NL; Guatelli JC
    Virology; 1996 Mar; 217(2):602-6. PubMed ID: 8610453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
    Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
    Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
    Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
    Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rev activity determines sensitivity of HIV-1-infected primary T cells to CTL killing.
    Bobbitt KR; Addo MM; Altfeld M; Filzen T; Onafuwa AA; Walker BD; Collins KL
    Immunity; 2003 Feb; 18(2):289-99. PubMed ID: 12594955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RevM10-mediated inhibition of HIV-1 replication in chronically infected T cells.
    Escaich S; Kalfoglou C; Plavec I; Kaushal S; Mosca JD; Böhnlein E
    Hum Gene Ther; 1995 May; 6(5):625-34. PubMed ID: 7578399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism.
    Wu BY; Woffendin C; Duckett CS; Ohno T; Nabel GJ
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1480-4. PubMed ID: 7878004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector.
    Inouye RT; Du B; Boldt-Houle D; Ferrante A; Park IW; Hammer SM; Duan L; Groopman JE; Pomerantz RJ; Terwilliger EF
    J Virol; 1997 May; 71(5):4071-8. PubMed ID: 9094685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages.
    Auten J; Agarwal M; Chen J; Sutton R; Plavec I
    Hum Gene Ther; 1999 May; 10(8):1389-99. PubMed ID: 10365668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.
    VandenDriessche T; Chuah MK; Chiang L; Chang HK; Ensoli B; Morgan RA
    J Virol; 1995 Jul; 69(7):4045-52. PubMed ID: 7769662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
    Li G; Lisziewicz J; Sun D; Zon G; Daefler S; Wong-Staal F; Gallo RC; Klotman ME
    J Virol; 1993 Nov; 67(11):6882-8. PubMed ID: 8411393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.
    Cordelier P; Van Bockstaele E; Calarota SA; Strayer DS
    Mol Ther; 2003 Jun; 7(6):801-10. PubMed ID: 12788654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication.
    San José E; Muñoz-Fernández MA; Alarcón B
    Hum Gene Ther; 1998 Jun; 9(9):1345-57. PubMed ID: 9650619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivation of a biologically contained replication system for human immunodeficiency virus type 1.
    Chen H; Boyle TJ; Malim MH; Cullen BR; Lyerly HK
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7678-82. PubMed ID: 1502183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.